This section contains press releases and other materials from third parties (including paid content). The Globe and Mail has not reviewed this content. Please see disclaimer.

Analysts Are Bullish on These Healthcare Stocks: Crescent Biopharma (CBIO), IQVIA Holdings (IQV)

Tipranks - Tipranks - Tue Jun 2, 8:44AM CDT

There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Crescent Biopharma (CBIO) and IQVIA Holdings (IQV) with bullish sentiments.

Claim 55% Off TipRanks

Crescent Biopharma (CBIO)

In a report released today, Robert Driscoll from Wedbush maintained a Buy rating on Crescent Biopharma, with a price target of $27.00. The company’s shares closed last Monday at $19.08.

According to TipRanks.com, Driscoll is a 4-star analyst with an average return of 8.6% and a 43.1% success rate. Driscoll covers the Healthcare sector, focusing on stocks such as Black Diamond Therapeutics, Monte Rosa Therapeutics, and Arvinas Holding Company. ;'>

The word on The Street in general, suggests a Strong Buy analyst consensus rating for Crescent Biopharma with a $31.00 average price target, implying a 50.1% upside from current levels. In a report issued on May 26, Piper Sandler also maintained a Buy rating on the stock with a $35.00 price target.

See Insiders’ Hot Stocks on TipRanks >>

IQVIA Holdings (IQV)

Argus Research analyst David Toung maintained a Buy rating on IQVIA Holdings on May 29. The company’s shares closed last Monday at $182.43, close to its 52-week low of $176.03.

According to TipRanks.com, Toung is a 4-star analyst with an average return of 8.3% and a 61.7% success rate. Toung covers the Healthcare sector, focusing on stocks such as GE Healthcare Technologies Inc, Integra Lifesciences, and Edwards Lifesciences. ;'>

IQVIA Holdings has an analyst consensus of Strong Buy, with a price target consensus of $214.33, a 17.6% upside from current levels. In a report issued on May 14, Truist Financial also maintained a Buy rating on the stock.

Read More on CBIO:

Disclaimer & DisclosureReport an Issue

This article contains syndicated content. We have not reviewed, approved, or endorsed the content, and may receive compensation for placement of the content on this site. For more information please view the Barchart Disclosure Policy here.

All market data (will open in new tab) is provided by Barchart Solutions. Copyright © 2026.

Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice. For exchange delays and terms of use, please read disclaimer (will open in new tab).